Le Lézard
Classified in: Science and technology
Subject: Product/Service

QuantConnect Launches Free Trial Periods for Alpha Streams Marketplace Strategies


QuantConnect, creator of the world's first alpha marketplace, Alpha Streams, today announced the launch of free trial periods for all algorithms listed on Alpha Streams. Starting today, institutional clients can leverage a free trial period to try out algorithms on Alpha Streams and prove their theories before paying to license them for a longer period.

QuantConnect provides its community of quants access to financial data, colocated infrastructure, and a coding environment where they can research, backtest, and live trade algorithmic trading strategies. Quants then have the opportunity to make these alphas available for licensing by Alpha Streams clients, which comprise leading U.S. quantitative hedge funds with an aggregate AUM of more than $50 billion.

During a free trial, portfolio managers may jumpstart the process of trying out an algorithm by conducting low-volume or paper trading without having to first gain purchasing authority. This novel approach to licensing alpha allows institutional investors to rapidly iterate and explore alpha from the QuantConnect community. Going forward, all Alpha Streams client funds, including a recently signed U.S. quantitative hedge fund with more than $10B AUM, can participate in these free trials.

All algorithms will have a default 30-day trial; however, the author is able to edit the length of their algorithm's trial period. Authors can set the trial period from a minimum of zero days to a maximum of 90 days per strategy. All trial periods are automatically applied when a fund licenses an algorithm, and after the free trial period, the licensing cost consists simply of a monthly licensing fee, with no profit-sharing or lock-in.

"We see free trial periods as a significant win-win for quants and institutions," commented Jared Broad, CEO and founder of QuantConnect. "Offering free trial periods will lower the barrier to entry for institutions wishing to use quants' algorithms by giving analysts and portfolio managers the unprecedented opportunity to prove the power of the high-quality algorithms on Alpha Streams before licensing them for a longer period. At the same time, quants will benefit from increased licensing rates."

"I've been building algorithms on the QuantConnect platform for five years, and being able to have my ideas licensed by hedge funds has been awesome," commented Chris Kramvis, Chief Investment Officer of DropShot Capital, who builds strategies on QuantConnect's platform. "I think adding free trial periods will generate more direct exposure for the community's strategies, and translate to more licensing revenue."

This development comes on the heels of several recent successes for QuantConnect. In addition to the signing of a U.S. quantitative hedge fund with more than $10B AUM, the company has seen record levels of user engagement and strategies created on its platform; with its recent competitions, QuantConnect has garnered 350 algorithm submissions and distributed $35,000 in prizes to the community. To learn more about QuantConnect and harnessing a global community of quants, visit quantconnect.com/funds.

About QuantConnect

QuantConnect is pioneering the world's first alpha marketplace, Alpha Streams, to provide opportunities to a global community of quants and make the financial markets more efficient. QuantConnect's open-source platform, LEAN, levels the playing field by providing cutting-edge quantitative trading technology to its community of 100,000 quants globally. Since its founding, QuantConnect's community of quants from 160+ countries has designed more than 2 million algorithms. With Alpha Streams, QuantConnect connects its community to institutional clients in order to supply quants with recognition and revenue for their ideas.To learn more about QuantConnect, visit quantconnect.com.


These press releases may also interest you

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...



News published on and distributed by: